Leonard Schleifer - Society for Science
Regeneron CEO Takes Industry Counterview On FTC News: “I'm Glad They're Looking Into This” :: Scrip
Meet the Queens-bred billionaires behind COVID drug-maker Regeneron
Leonard Schleifer
Regeneron on Twitter: "Find out from CEO Len Schleifer how $REGN got its name https://t.co/bHVi0QQ049 #TBT https://t.co/R74kBcOgTT" / Twitter
Watch CNBC's full interview with Regeneron CEO Len Schleifer - YouTube
Chapel Haven Schleifer Center, Inc. opens new chapter! – Chapel Haven
Q&A: Regeneron Founder – and UVA M.D./Ph.D. Alum – Discusses COVID-19 Treatment | UVA Today
Is pharma's biggest internal critic risking a reckoning? - STAT
Regeneron CEO on teaming up with Roche to develop Covid antibody cocktail
Leonard Schleifer - Society for Science
16th annual Double Helix Medals dinner raises $5M | Cold Spring Harbor Laboratory
Len Schleifer and George Yancopoulos | Cold Spring Harbor Laboratory
Does Drug Development Require A Passionate Commitment
College admissions scam prosecutor benefited from his own life of privilege
Regeneron CEO says "halo effect" of New York funding competition is good for business - Albany Business Review
Provider of Trump Covid drug is president's golf friend | Coronavirus | The Guardian
SPOTLIGHT! HARRIET AND LEONARD SCHLEIFER | Jewish Federation of Greater New Haven
Without equity awards, Regeneron's Schleifer made $7M in 2022
FDA Approves Regeneron and Sanofi's Dupixent for Eczema - WSJ
Entrepreneur of the Year shows power of persistence - Alumni, parents, and friends | Cornell University
Can a Billionaire's Son Spend His Way to a House Seat in New York? - The New York Times
